Received Jul 3, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | UNK | Z015658 | OT / RA |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | Z008441 | OT / RA |
No symptoms were reported; improperly stored vaccines were administered; This Spontaneous report was received from Other health professional and referred to a/an 22-years-old ( Race Unknown ) ( Ethnicity Unknown) Male Adult patient. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medication included Tdap (Diphtheria vaccine toxoid;Pertussis vaccine acellular;Tetanus vaccine toxoid). On 09-Jun-2026, the patient started therapy with sterile diluent solution for injection (0.70 mL) (Batch/Lot Number: 217168) via Intramuscular. On 09-Jun-2026, the patient started therapy with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live powder and solvent for solution for injection (0.50 mL) (Batch/Lot Number: Z008441) (Expiration date: 24-Nov-2026) dose form was Powder and solvent for solution for injection via Intramuscular (Anatomical Site:Right Arm). On 09-Jun-2026, the patient started therapy with Hepatitis B Vaccine (Recombinant), 10 mcg/mL Suspension for injection 64457236:4094 (Batch/Lot Number: Z015658) (Expiration date: 14-Jul-2028) dose form was Suspension for injection via Intramuscular (Anatomical Site:Right Arm). The patient started therapy with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live powder and solvent for solution for injection for the treatment of prophylaxis, The patient started therapy with Hepatitis B Vaccine (Recombinant), 10 mcg/mL Suspension for injection 64457236:4094 for the treatment of prophylaxis, On 09-Jun-2026, the patient experienced improperly stored vaccines were administered (Product storage issue). On an unknown date, the patient experienced No symptoms were reported (No adverse event). The Outcome of Product storage issue was not provided. The Outcome of No adverse event was not provided. The action taken with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live powder and solvent for solution for injection regarding Product storage issue was Not applicable with Not Applicable dechallenge and rechallenge results. The action taken with sterile diluent solution for injection regarding Product storage issue was Not applicable with Not Applicable dechallenge and rechallenge results. The action taken with Hepatitis B Vaccine (Recombinant), 10 mcg/mL Suspension for injection 64457236:4094 regarding Product storage issue was Not applicable with Not Applicable dechallenge and rechallenge results. Case Assessments: sterile diluent solution for injection regarding No adverse event with Not Applicable dechallenge and rechallenge results. Case Assessments: Hepatitis B Vaccine (Recombinant), 10 mcg/mL Suspension for injection 64457236:4094 regarding No adverse event with Not Applicable dechallenge and rechallenge results. Case Assessments: measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live powder and solvent for solution for injection regarding No adverse event with Not Applicable dechallenge and rechallenge results. The Other health professional considered the event Product storage issue (,) to be not assessed to measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live powder and solvent for solution for injection, the event No adverse event (,) to be not assessed to sterile diluent solution for injection, the event No adverse event (,) to be not assessed to Hepatitis B Vaccine (Recombinant), 10 mcg/mL Suspension for injection 64457236:4094, the event Product storage issue (,) to be not assessed to sterile diluent solution for injection, the event No adverse event (,) to be not assessed to measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live powder and solvent for solution for injection, and the event Product storage issue (,) to be not assessed to Hepatitis B Vaccine (Recombinant), 10 mcg/mL Suspension for injection 64457236:4094 The Other health professional considered the event No adverse event to be non-serious and the event Product storage issue to be non-serious The following updates were made to the case on 26-Jun-2026: The patient details were updated, including age group, age, age (normalized), date of birth (normalized), and sex. Details of suspect product SYRINGE (GLASS) 1.5ML LL were updated, including action taken. Details of suspect product Hepatitis B Vaccine (Recombinant), 10 mcg/mL Suspension for injection 64457236:4094 were updated, including patient roa and patient roa text. Details of suspect product sterile diluent solution for injection were updated, including patient roa and patient roa text. Details of suspect product measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live powder and solvent for solution for injection were updated, including patient roa and patient roa text. Linked Case(s): Same Reporter: US-009507513-2438308, Same Reporter: US-009507513-2438326, and Same Reporter: US-009507513-2438352
Tdap; MERCK STERILE DILUENT